Provided by Tiger Trade Technology Pte. Ltd.

IO Biotech, Inc.

0.8100
-0.0366-4.32%
Post-market: 0.7938-0.0162-2.00%17:23 EST
Volume:316.83K
Turnover:255.20K
Market Cap:58.28M
PE:-0.61
High:0.8310
Open:0.8300
Low:0.7800
Close:0.8466
52wk High:2.79
52wk Low:0.3234
Shares:71.95M
Float Shares:31.16M
Volume Ratio:0.30
T/O Rate:1.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3356
EPS(LYR):-1.4494
ROE:-240.48%
ROA:-88.58%
PB:63.97
PE(LYR):-0.56

Loading ...

Dec 27, 2024

Major Issues Report

Form 8-K - Current report
Dec 20, 2024

Major Issues Report

Form 8-K - Current report
Dec 16, 2024

Major Issues Report

Form 8-K - Current report
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Sep 17, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Sep 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 30, 2024

Major Issues Report

Form 8-K - Current report
Aug 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

Correspondence

Form CORRESP - Correspondence
Jul 25, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 11, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
May 14, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 26, 2024

Major Issues Report

Form 8-K - Current report
Mar 22, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]